XML 34 R27.htm IDEA: XBRL DOCUMENT v3.25.2
Business Combination (Tables)
3 Months Ended
Jun. 30, 2025
Business Combination [Abstract]  
Schedule of assets acquired and liabilities assumed

The Company's final allocation of the purchase price to the assets acquired, liabilities assumed, and noncontrolling interest recognized and redeemable as of the Closing Date were as follows:

(In thousands)

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

221

 

Accounts receivable

 

 

116

 

Materials and supplies

 

 

537

 

Operating lease right-of-use

 

 

3,063

 

Prepaid expenses and other assets

 

 

265

 

Property, plant, and equipment

 

 

24,584

 

Intangible assets

 

 

4,133

 

Goodwill

 

 

12,280

 

Total assets acquired

 

 

45,199

 

 

 

 

 

Accounts payable

 

 

1,252

 

Accrued expenses and other liabilities

 

 

112

 

Lease liabilities

 

 

3,063

 

Deferred income taxes

 

 

4,208

 

Deferred revenue

 

 

556

 

Total liabilities assumed

 

 

9,191

 

 

 

 

 

Total fair value of net assets acquired

 

 

36,008

 

Less: redeemable noncontrolling interest

 

 

(17,644

)

Total Adjusted Base Purchase Price

 

$

18,364

 

Schedule of net impact of the Acquisition on the Company's condensed consolidated statements of operations

The following is the net impact of the Amplex Acquisition on the Company's condensed consolidated statements of operations for the three months ended June 30, 2025 and 2024:

 

 

(In thousands)

 

 

 

Three months ended June 30,

 

 

 

2025

 

 

2024

 

Total revenue

 

$

3,034

 

 

$

489

 

 

 

 

 

 

 

 

Net income (loss) from continuing operations

 

$

74

 

 

$

(600

)

Schedule of business acquisition, pro forma information

The following table represents the supplemental consolidated financial results of the Company on an unaudited pro forma basis, as if the acquisition had been consummated on April 1, 2024.

 

(In thousands)

 

 

 

Three months ended June 30,

 

 

 

2025 (Actual)

 

 

2024 (Pro Forma)

 

Revenue

 

$

3,034

 

 

$

4,130

 

 

 

 

 

 

 

 

Net loss from continuing operations attributable to common shareholders

 

 

(786

)

 

 

(3,912

)

Net income from discontinued operations attributable to common shareholders

 

 

38

 

 

 

2,059

 

Net loss attributable to common shareholders

 

$

(748

)

 

$

(1,853

)

Schedule of noncash investing and financing activities

The following table represents the supplemental schedule of noncash investing and financing activities related to the Amplex acquisition:

 

 

(In thousands)

 

 

 

Three months ended June 30,

 

 

 

2025

 

 

2024

 

Supplemental schedule of noncash investing and financing activities

 

 

 

 

 

 

Fair value of Amplex assets acquired

 

$

-

 

 

$

45,199

 

Less: redeemable noncontrolling interest

 

 

-

 

 

 

(17,644

)

Less: cash paid for Amplex common stock

 

 

-

 

 

 

(18,364

)

Amplex liabilities assumed

$

-

 

 

$

9,191